CorVel (CRVL) Competitors $108.06 -0.23 (-0.21%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$108.06 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. LH, DGX, DVA, CHE, AMED, MD, AMN, CCRN, RYAN, and ERIEShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Ryan Specialty (RYAN), and Erie Indemnity (ERIE). CorVel vs. Its Competitors Laboratory Co. of America Quest Diagnostics DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Ryan Specialty Erie Indemnity CorVel (NASDAQ:CRVL) and Laboratory Co. of America (NYSE:LH) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, community ranking, profitability and institutional ownership. Does the MarketBeat Community prefer CRVL or LH? Laboratory Co. of America received 433 more outperform votes than CorVel when rated by MarketBeat users. Likewise, 63.92% of users gave Laboratory Co. of America an outperform vote while only 63.84% of users gave CorVel an outperform vote. CompanyUnderperformOutperformCorVelOutperform Votes19663.84% Underperform Votes11136.16% Laboratory Co. of AmericaOutperform Votes62963.92% Underperform Votes35536.08% Does the media favor CRVL or LH? In the previous week, CorVel had 1 more articles in the media than Laboratory Co. of America. MarketBeat recorded 12 mentions for CorVel and 11 mentions for Laboratory Co. of America. CorVel's average media sentiment score of 1.16 beat Laboratory Co. of America's score of 1.10 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Laboratory Co. of America 7 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, CRVL or LH? CorVel has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Which has better valuation & earnings, CRVL or LH? Laboratory Co. of America has higher revenue and earnings than CorVel. Laboratory Co. of America is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorVel$895.59M6.20$76.25M$1.8458.73Laboratory Co. of America$13.18B1.65$746M$8.6530.05 Is CRVL or LH more profitable? CorVel has a net margin of 10.12% compared to Laboratory Co. of America's net margin of 5.73%. CorVel's return on equity of 32.22% beat Laboratory Co. of America's return on equity.Company Net Margins Return on Equity Return on Assets CorVel10.12% 32.22% 17.66% Laboratory Co. of America 5.73%15.29%7.01% Do analysts recommend CRVL or LH? Laboratory Co. of America has a consensus price target of $274.00, indicating a potential upside of 5.40%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, analysts clearly believe Laboratory Co. of America is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Laboratory Co. of America 0 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.86 Do institutionals and insiders believe in CRVL or LH? 51.4% of CorVel shares are owned by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are owned by institutional investors. 47.6% of CorVel shares are owned by insiders. Comparatively, 0.8% of Laboratory Co. of America shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryLaboratory Co. of America beats CorVel on 10 of the 19 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelInsurance agents, brokers, & service IndustryBusiness SectorNASDAQ ExchangeMarket Cap$5.55B$17.68B$14.33B$8.63BDividend YieldN/A1.68%2.60%4.18%P/E Ratio63.5724.6234.3520.06Price / Sales6.206.80312.32157.10Price / Cash57.1925.6630.9334.64Price / Book18.4419.275.464.70Net Income$76.25M$708.45M$195.72M$247.88M7 Day Performance-1.37%-1.05%2.66%2.63%1 Month Performance-5.28%-6.43%3.69%6.36%1 Year Performance34.63%-1.43%24.28%14.05% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel0.9119 of 5 stars$108.06-0.2%N/A+37.8%$5.55B$895.59M63.574,230Positive NewsInsider TradeLHLaboratory Co. of America4.3665 of 5 stars$247.74-0.5%$272.92+10.2%+31.7%$20.74B$13.18B28.0975,500Positive NewsAnalyst ForecastDGXQuest Diagnostics4.8866 of 5 stars$174.31+0.6%$185.73+6.6%+25.6%$19.46B$10.16B22.6749,000Positive NewsDVADaVita3.846 of 5 stars$134.44-1.3%$164.50+22.4%-1.3%$10.15B$12.97B12.5270,000CHEChemed4.6365 of 5 stars$568.72-1.1%$674.00+18.5%+2.0%$8.32B$2.49B28.7414,200Positive NewsShort Interest ↑AMEDAmedisys3.2945 of 5 stars$94.49+0.4%$100.75+6.6%+5.5%$3.10B$2.37B37.5020,000Positive NewsMDPediatrix Medical Group1.415 of 5 stars$13.54-4.3%$16.67+23.1%+110.1%$1.16B$1.98B-11.287,850Positive NewsShort Interest ↑AMNAMN Healthcare Services4.3722 of 5 stars$20.28-3.9%$32.08+58.2%-59.0%$776.42M$2.85B-5.274,230Positive NewsCCRNCross Country Healthcare4.0899 of 5 stars$13.15-0.2%$17.93+36.3%-10.7%$431.10M$1.26B-262.952,700Positive NewsRYANRyan Specialty4.0563 of 5 stars$71.98+0.6%$75.58+5.0%+22.1%$18.89B$2.65B104.323,850Positive NewsERIEErie Indemnity1.6339 of 5 stars$359.69+0.3%N/A+0.8%$16.61B$3.99B33.656,040News Coverage Related Companies and Tools Related Companies LH Alternatives DGX Alternatives DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives RYAN Alternatives ERIE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.